Clinical Trial Update: CTSN Embolic Protection Trial [NA]

View source ↗

Summary

The CTSN Embolic Protection Trial is currently recruiting, listing delirium, ischemic stroke, and related cardiovascular/renal conditions (acute kidney injury, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Delirium
• Heart Valve Disease
• Kidney Injury
• Stroke

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Delirium, Ischemic Stroke | NA | Status: RECRUITING